Guardant Health, Inc.
Nasdaq: GH
- Raised $320 million (2017)
- 10 clinical trials, 6 active
- FDA-cleared or approved devices
- Founded 2011
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Tvardi Therapeutics, Inc.
Nasdaq: TVRD
- Raised $72 million (2021)
- 28 clinical trials, 1 active
- Research grants: $1.3 million
- Founded 2017
BioAtla, Inc.
Nasdaq: BCAB
- Raised $5.8 million (2015)
- 6 clinical trials, 2 active
- Research grants: $440,536
Quadrant Biosciences Inc
- Raised $3.5 million (2023)
- 1 clinical trial
- Research grants: $5.6 million
- Founded 2015
Rocket Pharmaceuticals, Inc.
Nasdaq: RCKT
- Raised $24 million (2011)
- 26 clinical trials, 10 active
- Research grants: $38 million
Aradigm Corp
- Raised $23 million (2016)
- 4 clinical trials
- Research grants: $3.6 million
Raydiant Oximetry, Inc.
- Raised $4.3 million (2024)
- 7 clinical trials, 1 active
- 1 FDA-registered device site
- Research grants: $4.3 million
Ionis Pharmaceuticals Inc
Nasdaq: IONS
- Raised $201 million (2012)
- 149 clinical trials, 20 active
- 1 FDA-registered drug site
MediWound Ltd.
Nasdaq: MDWD
- Raised $17 million (2022)
- 15 clinical trials, 4 active
- 1 FDA-registered drug site
Neurocrine Biosciences Inc
Nasdaq: NBIX
- 86 clinical trials, 17 active
- 1 FDA-registered drug site
- Research grants: $10 million
Supernus Pharmaceuticals, Inc.
Nasdaq: SUPN
- Raised $30 million (2012)
- 67 clinical trials, 8 active
- 1 FDA-registered drug site
Inspire Medical Systems, Inc.
NYSE: INSP
- Raised $13 million (2016)
- 13 clinical trials, 5 active
- FDA-cleared or approved devices
Biodexa Pharmaceuticals Plc
Nasdaq: BDRX
- Raised $5 million (2024)
- 4 clinical trials, 2 active
- Founded 2014
CareDx, Inc.
Nasdaq: CDNA
- Raised $22 million (2016)
- 15 clinical trials, 6 active
- FDA-cleared or approved devices
CorMedix Inc.
Nasdaq: CRMD
- Raised $850,000 (2012)
- 6 clinical trials, 2 active
- Research grants: $562,988
- Founded 2006
Embody, Inc.
- Raised $10 million (2022)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $447,814
Miromatrix Medical Inc.
- Raised $16 million (2018)
- 6 clinical trials
- Research grants: $4 million
- Founded 2009
Femasys Inc
Nasdaq: FEMY
- Raised $8 million (2025)
- 6 clinical trials, 2 active
- FDA-cleared or approved devices
Pharmajet, Inc.
- Raised $15 million (2021)
- 6 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $1.7 million
Myomo, Inc.
NYSE: MYO
- Raised $200,000 (2016)
- 5 clinical trials
- 1 FDA-registered device site
- Research grants: $144,645
Showing 180 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences